OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Mitchell F. Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 266-266
Open Access | Times Cited: 4
Mitchell F. Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 266-266
Open Access | Times Cited: 4
Showing 4 citing articles:
A Study of Combined Onabotulinumtoxin A and Hyaluronic Acid Filler for the Treatment of Enlarged Facial Pores
Vasanop Vachiramon, Sonphet Chirasuthat, Suphagan Boonpethkaew, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 38-38
Open Access
Vasanop Vachiramon, Sonphet Chirasuthat, Suphagan Boonpethkaew, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 38-38
Open Access
Consensus on the Cosmetic Use of a Novel Botulinum Neurotoxin Type A Product (NEWLUX®) for Facial Expression Muscles: 2024 Guidelines and Discussions by Korean Experts
Nark‐Kyoung Rho, Gee Young Bae, Moon Seop Choi, et al.
Toxins (2025) Vol. 17, Iss. 2, pp. 61-61
Open Access
Nark‐Kyoung Rho, Gee Young Bae, Moon Seop Choi, et al.
Toxins (2025) Vol. 17, Iss. 2, pp. 61-61
Open Access
Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report
Michael U. Martin, Clifton Ming Tay, Tuck Wah Siew
Toxins (2024) Vol. 16, Iss. 10, pp. 422-422
Open Access | Times Cited: 1
Michael U. Martin, Clifton Ming Tay, Tuck Wah Siew
Toxins (2024) Vol. 16, Iss. 10, pp. 422-422
Open Access | Times Cited: 1
Does the Diffusion Profile Differ Between Botulinum Toxin Type a Formulations? Implications for the Management of Post-Stroke Spasticity
Alessandro Picelli, Stefano Tamburin, Rita Di Censo, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 480-480
Open Access
Alessandro Picelli, Stefano Tamburin, Rita Di Censo, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 480-480
Open Access
Are We Missing Something About the Maximum Dosing of Botulinum Toxin Type A1 in Adult and Pediatric Patients with Spasticity?
Alessandro Picelli, Rita Di Censo, Stefano Tamburin, et al.
Toxins (2024) Vol. 16, Iss. 12, pp. 513-513
Open Access
Alessandro Picelli, Rita Di Censo, Stefano Tamburin, et al.
Toxins (2024) Vol. 16, Iss. 12, pp. 513-513
Open Access
